tradingkey.logo

Heartflow Inc

HTFL
27.740USD
+1.750+6.73%
收盘 02/06, 16:00美东报价延迟15分钟
2.32B总市值
亏损市盈率 TTM

Heartflow Inc

27.740
+1.750+6.73%

关于 Heartflow Inc 公司

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Heartflow Inc简介

公司代码HTFL
公司名称Heartflow Inc
上市日期Aug 08, 2025
CEOFarquhar (John C. M)
员工数量699
证券类型Ordinary Share
年结日Aug 08
公司地址331 E Evelyn Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94041
电话16502411221
网址https://www.heartflow.com/
公司代码HTFL
上市日期Aug 08, 2025
CEOFarquhar (John C. M)

Heartflow Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John C. M. Farquhar
Mr. John C. M. Farquhar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United states
42.95M
92.80%
United kingdom
1.52M
3.28%
Japan
1.46M
3.16%
Rest of europe
349.00K
0.75%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 2月3日 周二
更新时间: 2月3日 周二
持股股东
股东类型
持股股东
持股股东
占比
Bain Capital Life Sciences Investors, LLC
14.62%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
其他
61.76%
持股股东
持股股东
占比
Bain Capital Life Sciences Investors, LLC
14.62%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
其他
61.76%
股东类型
持股股东
占比
Investment Advisor
53.98%
Investment Advisor/Hedge Fund
12.51%
Hedge Fund
3.17%
Individual Investor
2.47%
Endowment Fund
0.37%
Bank and Trust
0.32%
Private Equity
0.18%
Pension Fund
0.14%
Research Firm
0.10%
其他
26.77%

机构持股

更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
129
59.51M
43.48%
--
2025Q4
149
60.27M
70.78%
+21.99M
2025Q3
46
45.42M
54.46%
+42.91M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Bain Capital Life Sciences Investors, LLC
12.45M
14.62%
--
--
Sep 30, 2025
HealthCor Partners Management LP
6.70M
7.86%
--
--
Sep 30, 2025
Wellington Management Company, LLP
4.88M
5.73%
+465.57K
+10.55%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.62M
5.42%
+1.33M
+40.42%
Sep 30, 2025
Capricorn Investment Group LLC
3.92M
4.61%
+3.92M
--
Aug 08, 2025
Hayfin Capital Management LLP
3.64M
4.27%
-1.00
-0.00%
Sep 30, 2025
Baillie Gifford & Co.
3.01M
3.53%
+415.89K
+16.06%
Sep 30, 2025
Schusterman Interests LLC
1.94M
2.28%
+1.94M
--
Sep 30, 2025
The Vanguard Group, Inc.
1.45M
1.7%
+285.27K
+24.45%
Sep 30, 2025
Capital International Investors
1.30M
1.52%
+1.30M
--
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
占比3.13%
Global X HealthTech ETF
占比1.75%
Fidelity Blue Chip Growth ETF
占比0.07%
T Rowe Price Small-Mid Cap ETF
占比0.06%
iShares Health Innovation Active ETF
占比0.02%
Schwab U.S. Small-Cap ETF
占比0.02%
Fidelity Nasdaq Composite Index ETF
占比0.01%
Schwab U.S. Broad Market ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI